Cargando…
Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents
The absence of biomarkers to accurately predict anticancer therapy response remains a major obstacle in clinical oncology. We applied a genome‐wide loss‐of‐function screening approach in human haploid cells to characterize genetic vulnerabilities to classical microtubule‐targeting agents. Using doce...
Autores principales: | Gerhards, Nora M., Blomen, Vincent A., Mutlu, Merve, Nieuwenhuis, Joppe, Howald, Denise, Guyader, Charlotte, Jonkers, Jos, Brummelkamp, Thijn R., Rottenberg, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983209/ https://www.ncbi.nlm.nih.gov/pubmed/29689640 http://dx.doi.org/10.1002/1878-0261.12307 |
Ejemplares similares
-
Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism
por: Loregger, Anke, et al.
Publicado: (2020) -
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
por: Gerhards, Nora M., et al.
Publicado: (2018) -
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt‐based anti‐cancer drugs
por: Planells‐Cases, Rosa, et al.
Publicado: (2015) -
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion
por: Kleinfelter, Lara M., et al.
Publicado: (2015) -
Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis
por: Loregger, Anke, et al.
Publicado: (2017)